Customized breast cancer therapy based on response to chemo
Treatments studied
Part of Cancer, Skin clinical trials.
This study tests whether using a personalized approach to treatment after chemotherapy can improve outcomes for people with HER2-positive or triple-negative breast cancer. It aims to tailor further therapy based on how well the tumor responds initially.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early-stage breast cancer (tumor size T1-T3 with no lymph node involvement or T1-T2 with limited node involvement).
- Your breast cancer is HER2-positive or triple-negative.
- You plan to receive chemotherapy and radiation therapy before any surgery.
- You are 18 years or older.
- You are not pregnant or breastfeeding, and you are not in prison.
- You are not taking any other experimental drugs for your breast cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether checking DNA from your blood (circulating tumor DNA) can help doctors choose the best neoadjuvant (pre-surgery) treatment for HER2-positive or triple-negative breast cancer. It aims to personalize therapy based on how your tumor responds.
This trial tests whether a customized treatment plan given before surgery can improve outcomes for women with early-stage HR-positive, HER2-positive breast cancer. The goal is to shrink the tumor and make surgery more effective.
This trial tests a personalized treatment plan for HER2-positive breast cancer before surgery. The treatment is adjusted based on how your cancer responds, aiming to give you the best possible outcome.
This trial tests a personalized treatment plan for HER2-positive breast cancer that has spread. It uses a blood test to track cancer DNA and adjust therapy, including treatments that may help prevent cancer from reaching the brain. The goal is to achieve long-term remission.
This trial tests a personalized approach to treating breast cancer that has spread to nearby lymph nodes. Your surgery and radiation will be tailored to how well your cancer responds to initial chemotherapy or hormone therapy.
This trial tests whether using tumor “genetics” (information from your biopsy) to guide radiation planning can improve treatment for triple-negative breast cancer. It may help by aiming radiation more precisely while still using standard approaches where needed.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.